CymaBay Therapeutics, Inc.

CBAY · NASDAQ
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Assets
Cash & Equivalents$206,535$273,721$35,482$59,150
Short-Term Investments$187,720$165,057$178,362$177,215
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$9,547$8,881$10,227$6,355
Total Curr. Assets$403,802$447,659$224,071$242,720
Property Plant & Equip (Net)$5,725$510$725$866
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$22,360$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,799$2,879$1,854$1,733
Total NC Assets$30,884$3,389$2,579$2,599
Other Assets$0$0$0$0
Total Assets$434,686$451,048$226,650$245,319
Liabilities
Payables$3,828$2,731$4,589$1,633
Short-Term Debt$10,007$206$374$537
Tax Payable$0$0$0$0
Deferred Revenue$1,689$1,632$1,632$33,733
Other Curr. Liab.$21,319$15,097$11,299$10,597
Total Curr. Liab.$36,843$19,666$17,894$46,500
LT Debt$104,487$104,091$99,248$94,630
Deferred Rev, NC$1,100$1,100$1,100$0
Deferred Tax Liab, NC$0-$104,091-$99,248$0
Other NC Liab.$0$0$0$0
Total NC Liab.$105,587$105,191$100,348$94,630
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$142,430$124,857$118,242$141,130
Equity
Pref Stock$0$0$0$0
Common Stock$11$18$17$17
Retained Earnings-$978,227-$936,325-$902,443-$901,635
AOCI$144-$62-$124-$70
Other Equity$1,270,328$1,262,560$1,010,958$1,005,877
Total Equity$292,256$326,191$108,408$104,189
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$434,686$451,048$226,650$245,319
Net Debt-$92,041-$169,424$64,140$36,017
CymaBay Therapeutics, Inc. (CBAY) Financial Statements & Key Stats | AlphaPilot